(See also Introduction to Brain Infections.)
Etiology
Encephalitis is usually a primary manifestation or a secondary (postinfectious) immunologic complication of viral infection.
Primary viral infection
Viruses causing primary encephalitis directly invade the brain. These infections may be
-
Epidemic (eg, due to arbovirus, echovirus, coxsackievirus, or poliovirus [in some underdeveloped countries])
-
Sporadic (eg, due to cytomegalovirus or to herpes simplex, varicella-zoster, lymphocytic choriomeningitis, rabies, or mumps virus)
Mosquito-borne arboviral encephalitides infect people during the spring, summer, and early fall when the weather is warm (see table Some Arboviral Encephalitides). Incidence in the US varies from 150 to > 4000 cases yearly, mostly in children. Most cases occur during epidemics.
Some Arboviral Encephalitides
|
Virus |
Distribution |
Mortality Rate |
Comments |
|
Florida, Puerto Rico, the US Virgin Islands Common in Africa, India, Guam, Southeast Asia, New Guinea, China, Mexico, Central America Reunion Islands, limited areas of Europe |
— |
Should be considered in US travelers who develop encephalitis after visiting endemic areas Can lead to severe encephalitis and even death, especially in infants and people > 65 |
|
|
Colorado tick fever virus |
Western US and Canada in areas that are 4,000 to 10,000 ft above sea level |
Rarely causes death |
Causes a nonspecific febrile illness, rarely complicated by meningitis or encephalitis |
|
Japanese encephalitis virus |
Asia and the western Pacific; uncommon in the US (mainly in travelers returning from endemic areas) |
< 1% overall, but up to 30% of severe cases |
Affects mainly children Usually mild and self-limiting, but severe in about 1 in 250 cases Vaccine used in endemic areas and recommended for travelers to these areas |
|
La Crosse virus (California virus) |
Primarily in the north central US but geographically widespread |
Probably < 1% |
Is probably underrecognized Accounts for most cases of arbovirus encephalitis in children |
|
St. Louis encephalitis virus |
Mostly in urban areas of the central and southeastern US but also in western states |
— |
Occurs in periodic urban epidemics; otherwise sporadic and rare |
|
Powassan virus |
Primarily in the northeastern states and the Great Lakes region of the US Southeastern Canada and Russia (southeastern Siberia, northeast of Vladivostok) |
About 10% |
Although rare, appears to be increasing since 2007; occurs in the late spring to mid-fall, when ticks are most active Should be considered in patients with encephalitis, especially those with a history of tick bite, a lot of time spent outdoors, and/or residence in or recent travel to an endemic area |
|
Tick-borne encephalitis virus |
Northern Asia, Russia, and many parts of Europe |
Usually 1–2% but varies based on subtype (0.5–35%) |
Occurs from early spring to late summer when ticks are most active Highest incidence and most severe symptoms in people ≥ 50 years Should be suspected in travelers who have a nonspecific febrile illness that progresses to neuroinvasive disease within 4 weeks after arriving from an endemic area and who may have been exposed to ticks |
|
Venezuelan equine encephalitis |
Mainly in parts in South and Central America; only rarely in the US (mainly in travelers returning from endemic areas) |
0–1%, primarily in children |
Vaccine available for equines; investigational vaccine used in laboratory workers at risk |
|
West Nile virus |
Throughout the continental US and other parts of North America Africa, Europe, the Middle East, and West Asia |
About 9% of patients with involvement of the central nervous system (CNS) |
As of 2017, spread from the East Coast, where it first appeared in 1999, to all of the western states |
|
Eastern equine encephalitis virus |
Eastern US; a few cases in the Great Lakes states |
About 50‒70% |
Occurs as small epidemics every 10‒20 years, mainly among young children and people > 55 |
|
Western equine encephalitis virus |
— |
— |
For unknown reasons, has largely disappeared from the US since 1988 |
|
Florida South America, Central America, Caribbean Islands, Pacific Islands, Cape Verde (a nation of islands off the northwest coast of Africa), Southeast Asia |
— |
May cause a dengue-like illness and has been implicated in causing Guillain-Barré syndrome, severe brain damage, and microcephaly in infants of infected mothers |
In the US, the most common sporadic encephalitis is caused by herpes simplex virus (HSV); hundreds to several thousand cases occur yearly. Most are due to HSV-1, but HSV-2 may be more common among immunocompromised patients. HSV encephalitis occurs at any time of the year, tends to affect patients < 20 or > 40 years, and is often fatal if untreated.
Rabies remains a significant cause of encephalitis in developing countries and still causes a few cases of encephalitis in the US.
Encephalitis can also occur as a late reactivation of latent or subclinical viral infection. The best known types are
-
Subacute sclerosing panencephalitis (which occurs years after a measles infection and is thought to represent reactivation of the original infection; it is now rare in Western countries)
-
Progressive multifocal leukoencephalopathy (which is caused by reactivation of JC virus; particularly in AIDS or immunosuppressed patients)
-
Herpes simplex type 1 and herpes zoster encephalitis
Immunologic reaction
Encephalitis can occur as a secondary immunologic complication of certain viral infections or vaccinations. Inflammatory demyelination of the brain and spinal cord can occur 1 to 3 weeks later (as acute disseminated encephalomyelitis); the immune system attacks one or more central nervous system (CNS) antigens that resemble proteins of the infectious agent. The most common causes of this complication used to be measles, rubella, chickenpox, and mumps (all now uncommon because childhood vaccination is widespread); smallpox vaccine; and live-virus vaccines (eg, the older rabies vaccines prepared from sheep or goat brain). In the US, most cases now result from influenza A or B virus, enteroviruses, Epstein-Barr virus, hepatitis A or hepatitis B virus, or HIV. Immunologically mediated encephalitis also occurs in patients with cancer and other autoimmune disorders.
Rarely, apparent encephalitis has developed in patients with COVID-19, caused by the novel pandemic severe acute respiratory syndrome coronavirus (SARS-CoV2); the mechanism is not clear, but an immunologic contribution to the mechanism of apparent encephalitis is possible, as is direct viral invasion of the brain.
Encephalopathies caused by autoantibodies to neuronal membrane proteins (eg, N-methyl-d-aspartate [NMDA] receptors) may mimic viral encephalitis. Some evidence suggests that anti-NMDA receptor encephalitis is a more common type of encephalitis than was previously thought. It occasionally develops after encephalitis due to herpes simplex virus, even when the encephalitis was successfully treated.
Pathophysiology
In acute encephalitis, inflammation and edema occur in infected areas throughout the cerebral hemispheres, brain stem, cerebellum, and, occasionally, spinal cord. Petechial hemorrhages may be present in severe infections. Direct viral invasion of the brain usually damages neurons, sometimes producing microscopically visible inclusion bodies. Severe infection, particularly untreated herpes simplex virus (HSV) encephalitis, can cause brain hemorrhagic necrosis.
Acute disseminated encephalomyelitis is characterized by multifocal areas of perivenous demyelination and absence of virus in the brain.
Symptoms and Signs
Symptoms of encephalitis include fever, headache, and altered mental status, often accompanied by seizures and focal neurologic deficits. A gastrointestinal (GI) or respiratory prodrome may precede these symptoms. Meningeal signs are typically mild and less prominent than other manifestations.
Status epilepticus, particularly convulsive status epilepticus, or coma suggests severe brain inflammation and a poor prognosis.
Olfactory seizures, manifested as an aura of foul smells (rotten eggs, burnt meat), indicate temporal lobe involvement and suggest HSV encephalitis.
Diagnosis
Encephalitis is suspected in patients with unexplained alterations in mental status. Clinical presentation and differential diagnoses may suggest certain diagnostic tests, but MRI and CSF analysis (including polymerase chain reaction [PCR] for HSV and other viruses) are usually done, typically with other tests (eg, serologic tests) to identify the causative virus. Despite extensive testing, the cause of many cases of encephalitis remains unknown.
MRI
Contrast-enhanced MRI is sensitive for early HSV encephalitis, showing edema in the orbitofrontal and temporal areas, which HSV typically infects. MRI shows demyelination in progressive multifocal leukoencephalopathy and may show basal ganglia and thalamic abnormalities in West Nile and eastern equine encephalitis. MRI can also exclude lesions that mimic viral encephalitis (eg, brain abscess, sagittal sinus thrombosis).
CT is much less sensitive than MRI for HSV encephalitis but can help because it is rapidly available and can exclude disorders that make lumbar puncture risky (eg, mass lesions, hydrocephalus, cerebral edema).
CSF testing
Lumbar puncture (spinal tap) is done. If encephalitis is present, CSF is characterized by lymphocytic pleocytosis, normal glucose, mildly elevated protein, and an absence of pathogens after Gram staining and culture (similar to CSF in aseptic meningitis). Pleocytosis may be polymorphonuclear in severe infections. CSF abnormalities may not develop until 8 to 24 hours after onset of symptoms. Hemorrhagic necrosis can introduce red blood cells (RBCs) into CSF and elevate protein. CSF glucose levels may be low when the cause is varicella-zoster virus, mumps, or lymphocytic choriomeningitis virus.
PCR testing of CSF is the diagnostic test of choice for HSV-1, HSV-2, varicella-zoster virus, cytomegalovirus, enteroviruses, and JC virus. PCR for HSV in CSF is particularly sensitive and specific. However, results may not be available rapidly, and despite advances in technology, false-negative and false-positive results may still occur because of a variety of conditions; not all are technical failures (eg, the blood in a mildly traumatic CSF tap may inhibit the PCR amplification step). False-negative results can occur early in HSV-1 encephalitis; in such cases, testing should be repeated in 48 to 72 hours. A new technique, next-generation sequencing is becoming more widely available and may identify nucleic acids of agents that otherwise escape detection.
CSF viral cultures grow enteroviruses but not most other viruses. For this reason, CSF viral cultures have been superseded by PCR and are rarely used in diagnosis.
CSF viral IgM titers are often useful for diagnosing acute infection, especially West Nile encephalitis, for which they are more reliable than PCR. CSF IgG and IgM titers may be more sensitive than PCR for varicella-zoster virus encephalitis. Paired acute and convalescent serologic tests of CSF and blood must be drawn several weeks apart; they can detect an increase in viral titers specific for certain viral infections.
Brain biopsy
Prognosis
Treatment
Supportive therapy for encephalitis includes treatment of fever, dehydration, electrolyte disorders, and seizures. Euvolemia should be maintained.
Because prompt identification of HSV or varicella-zoster virus by PCR is difficult, treatment should not be withheld pending confirmation by testing. Until HSV encephalitis and varicella-zoster virus encephalitis are excluded, acyclovir 10 mg/kg IV every 8 hours should be started promptly and continued usually for 14 days or until infection with these viruses is excluded. Acyclovir is relatively nontoxic but can cause liver function abnormalities, bone marrow suppression, and transient renal failure. Giving acyclovir IV slowly over 1 hour with adequate hydration helps prevent nephrotoxicity. Cytomegalovirus encephalitis can be treated with ganciclovir and/or other antiviral drugs.
Because a bacterial central nervous system (CNS) infection is often difficult to exclude when patients who appear seriously ill present, empiric antibiotics are often given until bacterial meningitis is excluded.
If encephalitis is due to an immunologic reaction (eg, acute disseminated encephalomyelitis [postinfectious encephalomyelitis]), treatment should be begun immediately; it may include corticosteroids (prednisone or methylprednisolone) and plasma exchange or IV immune globulin.
Key Points
-
Viruses that cause epidemic or sporadic infections can invade and infect brain parenchyma (causing encephalitis) and/or trigger postinfectious inflammatory demyelination (acute disseminated encephalomyelitis).
-
Encephalitis causes fever, headache, and altered mental status, often accompanied by seizures and focal neurologic deficits.
-
Do contrast-enhanced MRI and CSF testing.
-
Until HSV encephalitis and varicella-zoster virus encephalitis are excluded, promptly treat with acyclovir and continue, usually for 14 days or until infection with these viruses is excluded.
-
Treat encephalitis due to an immunologic reaction with corticosteroids and plasma exchange or IV immune globulin.
Drugs Mentioned In This Article
| Drug Name | Select Trade |
|---|---|
methylprednisolone |
MEDROL |
immune globulin |
Gammagard S/D |
ganciclovir |
CYTOVENE |
prednisone |
RAYOS |
acyclovir |
ZOVIRAX |
